Cocaine opens the blood-brain barrier to HIV-1 invasion

References

• Bacellar H., Munoz A., Miller E. N., Cohen B. A., Besley D., Seines O. A., Becker J. T., McArthur J.C. Temporal trends in the incidence of HIV-1 related neurologic diseases: Multi-center AIDS Cohort Study. Neurology 1994; 44: 1892–1900
   PubMed Web of Science ®Google Scholar
• Bagasra O., Pomerantz R.J. Human immunodeficiency virus type 1 replication in peripheral blood mononuclear cells in the presence of cocaine. J Infect Dis 1993; 168: 1157–1164
   PubMed Web of Science ®Google Scholar
• Bagasra O., Lavi E., Bobroski L., Khalili K., Pestaner J. P., Tawadros R., Pomerantz R.J. Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohisto-chemistry. Aids 1996; 10: 573–585
   PubMed Web of Science ®Google Scholar
• Bell M. D., Taub D. D., Perry V.H. Overriding the brain's intrinsic resistance to leukocyte recruitment with intraparenchymal injections of recombinant chemokines. Neuroscience 1996; 74: 283–292
   PubMed Web of Science ®Google Scholar
• Berger E. A., Doms R. W., Fenyo E. M., Korber BTM, Littman D. R., Moore J. P., Sattentau Q. J., Schuitemaker H., Sodroski J., Weiss R.A. A new classification for HIV-1. Nature 1998; 391: 240
   PubMed Web of Science ®Google Scholar
• Chao C. C., Gekker G., Sheng W. S., Hu S., Tsang M., Peterson P.K. Priming effect of morphine on the production of tumor necrosis factor-a by microglia: implications in respiratory burst activity and human immunodeficiency virus-1 expression. J Pharmacol Exp Ther 1994; 269: 198–203
   Web of Science ®Google Scholar
• Cocchi F., DeVico A. L., Garzino-Demo A., Arya S. K., Gallo R. C., Lusso P. Identification of RANTES, MlP-la and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995; 270: 1811–1815
   PubMed Web of Science ®Google Scholar
• Daras M., Tuchman A. J., Koppel B. S., Samkoff L. M., Weitzner I., Marc J. Neurovascular complications of cocaine. Acta Neurologica Scandinavica 1994; 90: 124–129
   Google Scholar
• Deng H. K., Liu R., Ellmeier W., Choe S., Unumatz D., Burkhart M., DiMarzio P., et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996; 381: 661–666
   PubMed Web of Science ®Google Scholar
• Doranz B. J., Rucker J., Yi Y., Smyth R. J., Samson M., Peiper S. C., Parmentier M., Collman R. G., Doms R.W. A dual-tropic primary HIV-1 isolate that uses fusin and the beta chemokine receptors CKR5, CKR4 and CKR2b as fusion co-factors. Cell 1996; 85: 1149–1158
   PubMed Web of Science ®Google Scholar
• Edinger A. L., Mankowski J. L., Doranz B. J., Margulies B. J., Lee B., Rucker J., Sharron M., Hoffman T. L., Berson J. F., Zink M. C., Hirsch V. M., Clements J. E., Doms R.W. CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by a neurovirulent simian immunodeficiency virus strain. Froc. Natl Acad Sci USA 1997; 94: 14742–14747
   PubMed Web of Science ®Google Scholar
• Ellis R. J., Hsia K., Spector S. A., Nelson J. A., Heaton R. K., Wallace M. R., Abramson I., Atkinson J. H., Grant I., McCutchan J. A. HIV Neurobehavioral Research Center Group Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. Ann Neurol 1997; 42: 679–688
   PubMed Web of Science ®Google Scholar
• Elovaara I., Seppala I., Poutianen S., Sun J., Valle S-L. Intrathecal humoral immunologic response in neurologically symptomatic and asymptomatic patients with human immunodeficiency virus infection. Neurology 1998; 38: 1451
   Google Scholar
• Feng Y., Broder C. C., Kennedy P. E., Berger C.C. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G-protein-coupled receptor. Science 1996; 272: 872–877
   PubMed Web of Science ®Google Scholar
• Fiala M., Gan X-H, Newton T., Chiappelli F., Shapshak P., Kermani V., Kung M. A., Diagne A., Martinez O., Graves M., Way D., Weinand M., Witte M. Divergent effects of cocaine on cytokine production by lymphocytes and monocyte/macrophages. Adv Exp Med Biol 1996a; 402: 145–156
   Google Scholar
• Fiala M., Rhodes R. H., Shapshak P., Nagano I., Martinez O. M., Diagne A., Baldwin G., Graves M. Regulation of HIV-1 infection in astrocytes: expression of Nef-oc and IL-6 is enhanced in coculture of astrocytes with macrophages. J Neurovirol 1996b; 2: 158–166
   Web of Science ®Google Scholar
• Fiala M., Looney D. J., Stins M., Way D., Zhang L., Gan X., Chiappelli F., Shapshak P., Weinand M., Graves M., Witte M., Kim K-S. TNF-α opens a paracellular route for HIV-1 invasion across the blood-brain barrier. Molecular Medicine 1997; 3: 553–564
   PubMed Web of Science ®Google Scholar
• Gendelman H., Persidsky Y., Ghorpade A., Limoges J., Stins M., Fiala M., Morrisett R. The neuropathogenesis of the AIDS dementia complex. AIDS 1994; 11((suppl A))S35–S45
   Google Scholar
• Gisslén M., Chiodi F., Fuchs D., Norkrans G., Svennerholm B., Wachter H., Hagberg L. Markers of immune stimulation in the cerebrospinal fluid during HIV infection: a longitudinal study. Scand J Infect Dis 1997; 26: 523–533
   Google Scholar
• Gray F., Lesces M-C, Keohane C., Paraire F., Marc B., Durignon M., Gherardi R. Early brain changes in HIV infection: Neuropathological study of 11 HIV seropositive, non-AIDS cases. J Neuropathol Exp Neurol 1992; 51: 177–185
   PubMed Web of Science ®Google Scholar
• Handelsman L., Aronson M., Maurer G., Wiener J., Jacobson J., Bernstein D., Ness H. S., Lasonczy M., Song IS., et al. Neuropsychological and neurological manifestations of HIV-1 dementia in drug users. J Neuropsych Clin Neurosci 1992; 4: 21–28
   Google Scholar
• He J., Chen Y., Farzan M., Choe H., Ohagen A., Gartner S., Busciglio J., Yang X., Hofmann W., Newman W., et al. CCR3 and CCR5 are co-receptors for HTV-1 infection of microglia. Nature 1997; 385: 645–649
   PubMed Web of Science ®Google Scholar
• Holman B. L., Garada B., Johnson K. A., Mendelson J., Hallring E., Teoh S. K., Worth J., Navia B. A comparison of brain perfusion SPECT in cocaine abuse and AIDS dementia complex. J Nuclear Medicine 1992; 33: 1312–1315
   PubMed Web of Science ®Google Scholar
• Liao F., Alkhatib G., Peden K. W., Sharma G., Berger E. A., Farber J.M. STRL33, a novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1. J Exp Med 1997; 185: 2015–2023
   PubMed Web of Science ®Google Scholar
• Kibyashi K., Mastri A. R., Hirsch C.S. Neuropathology of human immunodeficiency virus infection at different disease stages. Human Pathol 1996; 7: 637–642
   Google Scholar
• Koutsilieri E., Gotz M. E., Sopper S., Sauer U., Demuth M., ter Meulen V., Riederer P. Regulation of glutathione and cell toxicity following exposure to neurotropic substances and human immunodeficiency virus-1 in vitro. J Neurovirol 1997; 3: 342–349
   PubMed Web of Science ®Google Scholar
• Massari F. E., Poli G., Schnittman S. M., Psallidopoulos M. C., Davey V., Fauci A.S. In vivo T lymphocyte origin of macrophage-tropic strains of HIV. Role of monocytes during in vitro isolation and in vivo infection. J Immunol 1990; 144: 4628–4632
   Google Scholar
• McArthur J. C., Sipos E., Cornblath D. R., Welch D., Chupp M., Griffin D. E., Johnson R.T. Identification of mononuclear cells in CSF of patients with HIV infection. Neurology 1989; 39: 66–70
   Google Scholar
• McArthur J. C., McClernon D. R., Cronin M. F., Nance-Sproson T. E., Saah A. J., St Clair M., Lanier E.R. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain. Ann Neurol 1997; 42: 689–698
   PubMed Web of Science ®Google Scholar
• Mody CK, et al. Neurologic complications of cocaine. Neurology 1988; 38: 1181–1183
   Google Scholar
• Moses A. V., Bloom F. E., Pauza C. D., Nelson J.A. Human immunodeficiency virus infection of human brain capillary endothelial cells occur via a CD4J galactosylceramide-independent mechanism. Proc Natl Acad Sci USA 1993; 90: 10474–10478
   PubMed Web of Science ®Google Scholar
• Piatak M., Jr, Saag M. S., Yang L. C., Clark S. J., Kappes J. C., Luk K. C., Hahn B. C., Shaw G. M., Lifson J.D. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993; 259: 1749–1754
   PubMed Web of Science ®Google Scholar
• Poli G, Fauci AS. The role of monocyteJ macrophages and cytokines in the pathogenesis of HIV infection. Pathobiology 1992; 60: 246–251
   PubMedGoogle Scholar
• Robertson K., Fiscus S., Kappor C., Robertson W., Schneider G., Shepard R., Howe L., Silva S., Hall C. CSF, plasma viral load and HIV associated dementia. J Neurovirol 1998; 4: 90–94
   Web of Science ®Google Scholar
• Schmidtmayerova H., Sherry B., Bukrinsky M. Chemokines and HIV replication. Nature 1996; 382: 676
   Google Scholar
• Spector S. A., Hsia K., Pratt D., Lathey J., McCutchan A., Alcara J. E., Atkinson JH., et al. Virologic markers of human immunodeficiency virus type 1 in cerebrospinal fluid. J Infect Dis 1993; 168: 68–74
   Google Scholar
• Strickland TL, et al. Cerebral perfusion and neuropsychological consequences of chronic cocaine use. J Neuropsych Clin Neurosci 1993; 5: 419–427
   PubMed Web of Science ®Google Scholar
• Wellman MC. Neuropsychological impairment among intravenous drug users in pre-AIDS stages of HIV infection. Int J Neurosci 1992; 64: 183–194
   PubMed Web of Science ®Google Scholar
• Wilt S. G., Milward E., Zhou J. M., Nagasato K., Patton H., Rusten R., Griffen D. E., O'Connor M., Dubois-Dalcq M. In vitro evidence for a dual role of tumor necrosis factor-a in human immunodeficiency virus type 1 (HIV-l) encephalopathy. Ann Neurol 1995; 37: 381–394
   Web of Science ®Google Scholar
• Wu Y-B, Shen M-L, Gu G. G., Anderson K. M., Ou D.W. The effects of cocaine injections on mouse thymocyte population. Proc Soc Exp Biol Med 1997; 214: 173–176
   PubMed Web of Science ®Google Scholar